{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:42:17Z","timestamp":1789058537919,"version":"build-2803163510"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circ: Heart Failure"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Current guidance from International Society for Heart and Lung Transplantation recommends using body weight for donor-recipient size matching for heart transplantation. However, recent studies have shown that predicted heart mass, using body weight, height, age, and sex, may represent a better method of size matching. We aim to validate a cardiovascular magnetic resonance (CMR)\u2013derived equation for predicted left ventricular mass (LVM) in a cohort of normal individuals in the United Kingdom.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This observational study was conducted in 5065 middle-aged (44\u201377 years old) UK Biobank participants who underwent CMR imaging in 2014 to 2015. Individuals with cancer diagnosis in the previous 12 months or history of cardiovascular disease were excluded. Predicted LVM was calculated based on participants\u2019 sex, height, and weight recorded at the time of imaging. Correlation analyses were performed between the predicted LVM and the LVM obtained from manual contouring of CMR cine images. The analysis included 3398 participants (age 61.5\u00b17.5 years, 47.8% males).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>\n              Predicted LVM was considerably higher than CMR-derived LVM (mean\u00b1SD of 138.8\u00b128.9 g versus 86.3\u00b120.9 g). However, there was a strong correlation between the 2 measurements (Spearman correlation coefficient 0.802,\n              <jats:italic>P<\/jats:italic>\n              &lt;0.0001).\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Predicted LVM calculated using a CMR-derived equation that incorporates height, weight, and sex has a strong correlation with CMR LVM in large cohort of normal individuals in the United Kingdom. Our findings suggest that predicted heart mass equations may be a valid tool for donor-recipient size matching for heart transplantation in the United Kingdom.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/circheartfailure.119.006362","type":"journal-article","created":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T10:00:16Z","timestamp":1575626416000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Validation of Cardiovascular Magnetic Resonance\u2013Derived Equation for Predicted Left Ventricular Mass Using the UK Biobank Imaging Cohort"],"prefix":"10.1161","volume":"12","author":[{"given":"Kenneth","family":"Fung","sequence":"first","affiliation":[{"name":"William Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London, Charterhouse Square, United Kingdom (K.F., J.A.C., S.E.P.)."},{"name":"Barts Heart Centre, St Bartholomew\u2019s Hospital, Barts Health NHS Trust, London, United Kingdom (K.F., S.E.P.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Cheshire","sequence":"additional","affiliation":[{"name":"Advanced Heart Failure and Transplant Unit, Royal Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom (C.C., P.C., S.B., S.P.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie A.","family":"Cooper","sequence":"additional","affiliation":[{"name":"William Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London, Charterhouse Square, United Kingdom (K.F., J.A.C., S.E.P.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Catarino","sequence":"additional","affiliation":[{"name":"Advanced Heart Failure and Transplant Unit, Royal Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom (C.C., P.C., S.B., S.P.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan K.","family":"Piechnik","sequence":"additional","affiliation":[{"name":"NIHR Oxford Biomedical Research Centre, Division of Cardiovascular Medicine, University of Oxford, United Kingdom (S.K.P., S.N.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Neubauer","sequence":"additional","affiliation":[{"name":"NIHR Oxford Biomedical Research Centre, Division of Cardiovascular Medicine, University of Oxford, United Kingdom (S.K.P., S.N.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Bhagra","sequence":"additional","affiliation":[{"name":"Advanced Heart Failure and Transplant Unit, Royal Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom (C.C., P.C., S.B., S.P.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Pettit","sequence":"additional","affiliation":[{"name":"Advanced Heart Failure and Transplant Unit, Royal Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom (C.C., P.C., S.B., S.P.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen E.","family":"Petersen","sequence":"additional","affiliation":[{"name":"William Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London, Charterhouse Square, United Kingdom (K.F., J.A.C., S.E.P.)."},{"name":"Barts Heart Centre, St Bartholomew\u2019s Hospital, Barts Health NHS Trust, London, United Kingdom (K.F., S.E.P.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2010.05.034"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-4975(94)90103-1"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(19)34077-2"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.103.6.820"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.95.7.1837"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(02)01712-6"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.04.1868"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.108.819938"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.09.014"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.985515"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2013.09.005"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2018.09.017"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2018.03.009"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1186\/1532-429X-15-46"},{"key":"e_1_3_5_16_2","unstructured":"WHO. International Classification of Diseases (ICD). Available at https:\/\/www.who.int\/classifications\/icd\/en\/. Accessed April 23 2019."},{"key":"e_1_3_5_17_2","unstructured":"Schnier C Bush K Nolan J Sudlow C. Definitions of Acute Myocardial Infarction and Main Myocardial Infarction Pathological Types UK Biobank Phase 1 Outcomes Adjudication On behalf of UK Biobank Outcome Adjudication Group. Available at http:\/\/biobank.ctsu.ox.ac.uk\/crystal\/crystal\/docs\/alg_outcome_mi.pdf. Accessed April 23 2019."},{"key":"e_1_3_5_18_2","unstructured":"Schnier C Bush K Nolan J Sudlow C. Definitions of Stroke for UK Biobank Phase 1 Outcomes Adjudication On behalf of UK Biobank Outcome Adjudication Group. Available at https:\/\/biobank.ctsu.ox.ac.uk\/crystal\/crystal\/docs\/alg_outcome_stroke.pdf. Accessed April 23 2019."},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12968-016-0227-4"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12968-017-0327-9"},{"key":"e_1_3_5_21_2","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2016","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2016."},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.1178"}],"container-title":["Circulation: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCHEARTFAILURE.119.006362","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T01:49:57Z","timestamp":1715564997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCHEARTFAILURE.119.006362"}},"subtitle":["Tool for Donor-Recipient Size Matching"],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["10.1161\/CIRCHEARTFAILURE.119.006362"],"URL":"https:\/\/doi.org\/10.1161\/circheartfailure.119.006362","relation":{},"ISSN":["1941-3289","1941-3297"],"issn-type":[{"value":"1941-3289","type":"print"},{"value":"1941-3297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"2019-06-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e006362"}}